Delivery Order SPE2DB25D3008-SPE2DB25FRBXA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,501.50 for Trulicity 3 mg/0.5 mL pens on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $14,757.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes treatment medication commonly used within military and...
- The Defense Logistics Agency awarded a delivery order valued at $1,051.05 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This delivery order represents a firm fixed price, competitively awarded contract with no set-aside designation. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,667.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on April 28, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by April 29, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used to improve blood sugar control in patients with type 2 diabetes,...
- The Defense Logistics Agency awarded a delivery order valued at $24,668.24 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on May 7, 2025, with an ultimate completion date of May 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a prescription diabetes medication used for managing type 2 diabetes and cardiovascular...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,000.54 for Trulicity 1.5 mg/0.5 ml pens on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly utilized within military and federal healthcare systems, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $11,274.71 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a injectable diabetes medication, reflecting the company's role as...
- The Defense Logistics Agency awarded a delivery order valued at $4,092.92 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication used to improve blood sugar control in patients with type 2...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,458.30 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger contract vehicle and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. Trulicity is a prescription diabetes medication commonly used within military...
- The Defense Logistics Agency awarded a $3,073.44 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRBXADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,016.73 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a branded diabetes medication used to improve blood sugar control in patients with type 2 diabetes. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the federal government, AmerisourceBergen serves as a critical supplier of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's role as a major pharmaceutical distributor enables it to fulfill federal medical procurement requirements across a broad therapeutic portfolio on a competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 4/24/25 |